Clinical Trial Update: RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating RNA-Lipid Particle vaccines for recurrent glioblastoma; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• RNA-Lipid Particle (RNA-LP) Vaccine

Snippet

Sponsor: University of Florida | Conditions: Recurrent Glioblastoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING